TCM as an Adjuvant Treatment in Breast Cancer Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversiti Tunku Abdul Rahman
About this trial
Chinese herbs can alleviates the side effects caused by conventional treatment in breast cancer patients and affects the syndrome element differentiation by altering the specific set of proteomes at specific time point of treatment.
Eligibility criteria
Qualifiers
Postmenopausal women as determined by cessation of menses for at least 1 year or FSH>20 mIU/mL
Histology confirmed stage 2 to 3 hormone-receptor positive breast cancer patient
Currently taking letrozole for at least 1 month
Reported ongoing musculoskeletal pain or stiffness, which started or worsened after initiation of letrozole
Disqualifiers
Pregnant or nursing woman or woman of childbearing potential without effective method of birth control.
Patients who default subsequent follow-up/ has irregular follow-up.
Patients who directly involved in other study at the same time.
History of non-compliance to medical regime and patients who are unwilling or unable to comply with the protocol.
Trial design
Treatments tested in this trial
- Chinese Herbs
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov